Steven Cohen’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,002,978
Closed -$99.5M 1349
2019
Q3
$99.5M Buy
1,002,978
+999,295
+27,133% +$99.2M 0.61% 34
2019
Q2
$365K Buy
+3,683
New +$351K ﹤0.01% 895
2018
Q3
Sell
-59,400
Closed -$5.55M 1299
2018
Q2
$5.55M Buy
+59,400
New +$5.12M 0.02% 579
2017
Q4
Sell
-77,500
Closed -$5.9M 1161
2017
Q3
$5.9M Buy
77,500
+52,500
+210% +$3.97M 0.03% 510
2017
Q2
$1.88M Sell
25,000
-242,913
-91% -$16.8M 0.01% 662
2017
Q1
$17.5M Sell
267,913
-102,387
-28% -$6.03M 0.1% 272
2016
Q4
$20.4M Buy
+370,300
New +$20.3M 0.14% 184

Other funds holding PRAH

Steven Cohen's PRAH Position: Q4 2019 in Review

Steven Cohen sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 1,002,978 shares — an estimated $99.5M sold.

Steven Cohen first reported a position in PRAH in Q4 2016 and held it in 7 quarters. The position peaked at $99.5M in Q3 2019. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Steven Cohen reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Steven Cohen sold 1,002,978 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $99.5M.
  • Steven Cohen first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 7 quarters.
  • Steven Cohen's PRA Health Sciences, Inc. position peaked at $99.5M in Q3 2019.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Point72 Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.